Mohammad Jahanzeb, MD | Authors

Articles

Dr. Mohammad Jahanzeb on Neratinib and Trastuzumab in HER2-Positive Breast Cancer

November 19, 2015

Mohammad Jahanzeb, MD, medical director, Sylvester Comprehensive Cancer Center at Deerfield Beach, talks about the future of treatment for patients with HER2-positive breast cancer with drugs like neratinib and trastuzumab.